Hyperinsulinemia: The Metabolic Engine of Androgen Excess

Polycystic Ovary Syndrome (PCOS) is frequently mischaracterised as a purely gynaecological disorder. However, biological evidence suggests it is primarily a metabolic condition with reproductive manifestations. At the core of the PCOS mechanism lies hyperinsulinemia—an overproduction of insulin by the pancreas, often preceding any rise in blood glucose levels. While the National Health Service (NHS) often focuses on weight loss as a primary treatment, this approach ignores the complex biochemical loop where insulin acts as a co-gonadotropin. In a healthy endocrine system, Luteinizing Hormone (LH) triggers the ovarian theca cells to produce androgens, which are then converted to oestrogen by granulosa cells.

In the PCOS phenotype, hyperinsulinemia bypasses this regulation. Insulin acts directly on theca cells, upregulating the CYP17A1 enzyme, which is responsible for the rate-limiting step in androgen synthesis. Simultaneously, high insulin levels circulate to the liver, where they suppress the production of Sex Hormone-Binding Globulin (SHBG). This is a critical biological failure: SHBG is the protein responsible for 'mopping up' free testosterone in the blood. When SHBG is low, the percentage of free, biologically active testosterone rises, leading to the classic symptoms of hirsutism, acne, and androgenic alopecia.

Research published in the Journal of Clinical Endocrinology and Metabolism highlights that even lean women with PCOS often exhibit postprandial hyperinsulinemia, suggesting that the standard BMI-centric model of PCOS is fundamentally flawed. To address the root cause, one must look at the PI3K/Akt signalling pathway. When cells become resistant to insulin's glucose-uptake signals, the body compensates by pumping out more insulin, which continues to exert its 'mitogenic' or growth-stimulating effects on the ovaries. This leads to the characteristic 'string of pearls' follicular arrest seen on ultrasounds. Conventional medicine’s reliance on the combined oral contraceptive pill (COCP) merely masks these symptoms by providing synthetic hormones that induce a withdrawal bleed, but it does nothing to rectify the underlying hyperinsulinemia.

In fact, some progestins used in birth control can further exacerbate insulin resistance. A more biological approach involves sensitising the cells to insulin through strategic movement, such as resistance training which increases GLUT4 translocation, and the implementation of a diet low in glycaemic load to reduce the pancreatic demand. Understanding that PCOS is an 'overflow' of metabolic signalling transforms the patient from a victim of her hormones to a manager of her metabolism.